|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Medicine, Johns Hopkins University, Baltimore, Maryland, United States
* To whom correspondence should be addressed. E-mail: wagnerem{at}jhmi.edu.
Under conditions of chronic pulmonary ischemia, the bronchial circulation undergoes massive proliferation. However, little is known regarding the mechanisms that promote neovascularization. An expanding literature implicates ELR + CXC chemokines and their G-protein coupled receptor, CXCR2, as key proangiogenic components in the lung. We used a rat model of chronic pulmonary ischemia induced by left pulmonary artery ligation (LPAL) to study bronchial angiogenesis. Using a methacrylate mixture, we cast the systemic vasculature of the rat lung at weekly intervals after LPAL. 21 days after LPAL, numerous large, tortuous bronchial arteries were observed surrounding the left main bronchus that penetrated the left lung parenchyma. In stark contrast, the right lung was essentially devoid of vessels. We quantified bronchial neovascularization using 15 um radiolabelled microspheres to measure systemic blood flow to the left lung (n=12 rats). Results showed that by 21 days after LPAL, bronchial blood flow to the ischemic left lung had increased more than 10 fold compared to controls 2 days after LPAL (p<0.01). Focusing on the predominant rat CXC chemokine that signals through CXCR2, we measured increased levels of CINC-3 protein in left lung homogenates early (4 and 24 hrs; n=10 rats) after LPAL relative to paired right lung controls (p<0.01). Treatment with a neutralizing antibody to CXCR2 resulted in a significant decrease in neovascularization 21 days after LPAL (n=9 rats; p<0.01). Our results confirm the time course of bronchial angiogenesis in the rat and suggest the importance of CXC chemokines in promoting systemic neovascularization in the lung.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |